Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nutt

Showing results (561-570 of 790) with videos related to

Pageof 79
Sort By:
Journal of Sleep Research|June 25, 2009
Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodoneSpilios V Argyropoulos, Jane A Hicks, John R Nash, et al.
Synapse (New York, N.Y.)|November 16, 2004
Estimation of endogenous noradrenaline release in rat brain in vivo using [3H]RX 821002Robin J Tyacke, Emma S J Robinson, Maggie D M Lalies, et al.
Psychopharmacology|May 3, 2005
GABA-benzodiazepine receptor function in alcohol dependence: a combined 11C-flumazenil PET and pharmacodynamic studyA R Lingford-Hughes, S J Wilson, V J Cunningham, et al.
The American Journal of Psychiatry|January 1, 2026
Thresholding and Perfusion Considerations in Interpreting Reduced Brain Responsiveness With Escitalopram: Response to Knudsen et alMatthew B Wall, Lysia Demetriou, Bruna Giribaldi, et al.
The American Journal of Psychiatry|May 7, 2025
Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for DepressionMatthew B Wall, Lysia Demetriou, Bruna Giribaldi, et al.
Journal of Psychopharmacology (Oxford, England)|September 22, 2001
Crossover trial of pagoclone and placebo in patients with DSM-IV panic disorderJ J Sandford, S Forshall, C Bell, et al.
Biological Psychiatry|January 15, 1995
Behavioral and endocrine responses to clomipramine in panic disorder patients with or without alcoholismD T George, D J Nutt, R R Rawlings, et al.
Journal of Psychopharmacology (Oxford, England)|April 27, 2004
Imidazoline2 (I2) receptor- and alpha2-adrenoceptor-mediated modulation of hypothalamic-pituitary-adrenal axis activity in control and acute restraint stressed ratsDavid P Finn, Alan L Hudson, Hiroshi Kinoshita, et al.
Psychopharmacology|November 27, 2007
Effects of acute tyrosine/phenylalanine depletion on the selective processing of smoking-related cues and the relative value of cigarettes in smokersBrian Hitsman, James MacKillop, Anne Lingford-Hughes, et al.
Journal of Psychopharmacology (Oxford, England)|April 17, 2010
The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerabilityRobin L Carhart-Harris, Tim M Williams, Ben Sessa, et al.
Pageof 79

Showing results (561-570 of 790) with videos related to

Sort By:
Pageof 79
Journal of Sleep Research|June 25, 2009
Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodoneSpilios V Argyropoulos, Jane A Hicks, John R Nash, et al.
Synapse (New York, N.Y.)|November 16, 2004
Estimation of endogenous noradrenaline release in rat brain in vivo using [3H]RX 821002Robin J Tyacke, Emma S J Robinson, Maggie D M Lalies, et al.
Psychopharmacology|May 3, 2005
GABA-benzodiazepine receptor function in alcohol dependence: a combined 11C-flumazenil PET and pharmacodynamic studyA R Lingford-Hughes, S J Wilson, V J Cunningham, et al.
The American Journal of Psychiatry|January 1, 2026
Thresholding and Perfusion Considerations in Interpreting Reduced Brain Responsiveness With Escitalopram: Response to Knudsen et alMatthew B Wall, Lysia Demetriou, Bruna Giribaldi, et al.
The American Journal of Psychiatry|May 7, 2025
Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for DepressionMatthew B Wall, Lysia Demetriou, Bruna Giribaldi, et al.
Journal of Psychopharmacology (Oxford, England)|September 22, 2001
Crossover trial of pagoclone and placebo in patients with DSM-IV panic disorderJ J Sandford, S Forshall, C Bell, et al.
Biological Psychiatry|January 15, 1995
Behavioral and endocrine responses to clomipramine in panic disorder patients with or without alcoholismD T George, D J Nutt, R R Rawlings, et al.
Journal of Psychopharmacology (Oxford, England)|April 27, 2004
Imidazoline2 (I2) receptor- and alpha2-adrenoceptor-mediated modulation of hypothalamic-pituitary-adrenal axis activity in control and acute restraint stressed ratsDavid P Finn, Alan L Hudson, Hiroshi Kinoshita, et al.
Psychopharmacology|November 27, 2007
Effects of acute tyrosine/phenylalanine depletion on the selective processing of smoking-related cues and the relative value of cigarettes in smokersBrian Hitsman, James MacKillop, Anne Lingford-Hughes, et al.
Journal of Psychopharmacology (Oxford, England)|April 17, 2010
The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerabilityRobin L Carhart-Harris, Tim M Williams, Ben Sessa, et al.
Pageof 79